[Results of thyrostatic therapy of hyperthyroidism in patients with Basedow's disease and disseminated autonomy].
Up to now the results of drug treatment are unsatisfying. Treatment of more than 1-2 years did not decrease the occurrence of relapses. Thyroid suppression test and TRH test give the same indications concerning the outcome in cases with Graves' disease and disseminated autonomy (short-time prognosis). The relapse rate is distinctly higher in Graves' disease than in cases with disseminated autonomy (goitre class 3 excluded).
D005500:Follow-Up Studies; D006111:Graves Disease / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000188:drug therapy*; D008713:Methimazole / Q000627:therapeutic use*; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000097:blood; D013973:Thyrotropin-Releasing Hormone
D008713:Methimazole; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin
Ergebnisse der thyreostatischen Therapie der Hyperthyreose bei Patienten mit Morbus Basedow bzw. disseminierter Autonomie.